| Ticker Details |
VolitionRX Limited Common Stock
VolitionRX Ltd is a clinical-stage life sciences company. The company is engaged in developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases.
|
| IPO Date: |
April 1, 2012 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$27.11M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.09 | 3.39%
|
| Avg Daily Range (30 D): |
$0.01 | 4.42%
|
| Avg Daily Range (90 D): |
$0.01 | 4.37%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.19M |
| Avg Daily Volume (30 D): |
1.81M |
| Avg Daily Volume (90 D): |
2.04M |
| Trade Size |
| Avg Trade Size (Sh.): |
328 |
| Avg Trade Size (Sh.) (30 D): |
603 |
| Avg Trade Size (Sh.) (90 D): |
646 |
| Institutional Trades |
| Total Institutional Trades: |
12 |
| Avg Institutional Trade: |
$2.06M |
| Avg Institutional Trade (30 D): |
$.68M |
| Avg Institutional Trade (90 D): |
$.68M |
| Avg Institutional Trade Volume: |
.63M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.26M |
| Avg Closing Trade (30 D): |
$.68M |
| Avg Closing Trade (90 D): |
$.68M |
| Avg Closing Volume: |
984.71K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
|
|
|
|
Diluted EPS
|
$-.23
|
$-.05
|
$-.06
|
|
Revenue
|
$1.47M
|
$.63M
|
$.41M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-23.06M
|
$-5.41M
|
$-6.31M
|
|
Operating Income / Loss
|
$-22.7M
|
$-5.1M
|
$-6.3M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$-5.21M
|
$-2.06M
|
$-.34M
|
|
PE Ratio
|
|
|
|
|
|
|